Welcome to the e-CCO Library!

P146 Comparison of three histologic indices in ulcerative colitis: Evaluation from the Phase 2 study of upadacitinib (U-ACHIEVE)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Jairath1, W.J. Lee2, W. Zhou3, G. Heap3, J. Butler4, A.L. Shields5, S. Ollis5, N. Harpaz6

Created: Thursday, 30 January 2020, 10:12 AM
P146: Dysplasia Surveillance in inflammatory bowel disease—a cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Saraiva*1, I. Rosa1, J. Moleiro1, J. Pereira da Silva1, R. Fonseca1, A. Dias Pereira1

Created: Friday, 22 February 2019, 9:41 AM
P146: Initial response to induction treatment more important than type of induction treatment for achieving sustained steroid free remission at 1 year in new-onset paediatric Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Klomberg, R.(1);van der Wal, H.(1);Sarbagili, C.(2);Kemos, P.(3);Ruemelle, F.(4);Croft, N.(3);de Ridder, L.(1);Levine, A.(2);
Created: Friday, 11 February 2022, 3:52 PM
P146: Primary intestinal Epstein-Barr virus-associated NK/T-Cell lymphoproliferative disorder: a disease mimicking IBD
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Wang Z., Zhu M., Luo C., Mu J., Yu Z., Zhang H.

Created: Wednesday, 20 February 2019, 10:36 AM
P146: Risk factors of clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Calafat*1, T. Lobatón1, A. Hernández-Gallego2, M. Mañosa1, P. Torres-Rodriguez1, E. Cabré1, I. Ojanguren2, E. Domènech1

Created: Friday, 22 February 2019, 9:49 AM
P146: Stigmatization and resilience in inflammatory bowel disease patients at one-year follow-up
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Broglio, G.(1)*;Lenti, M.V.(1);Mengoli, C.(2);Borrelli De Andreis, F.(1);Vernero, M.(1);Pitotti, L.(1);Padovini, L.(1);Delliponti, M.(2);Klersy, C.(3);Corazza, G.R.(1);Di Sabatino, A.(1);
Created: Friday, 14 July 2023, 10:48 AM
P146: The Toronto IBD global endoscopic reporting (TIGER) score demonstrates significant correlation with fecal calprotectin, CRP and IBD Disk in Crohn's disease patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Zittan, E.(1,2);Steinhart, A.H.(3);Aran, H.(1);Milgrom, R.(3); Koifman, E.(1);Gralnek, I.M.(1); Zelber-Sagi, S.(2);Silverberg, M.S.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P146: Ultrasonography and perianal involvement in inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Bernardo1*, P. Lago2, T. Moreira2, D. Ferreira2, I. Pedroto2, F. Castro-Poças2

Created: Thursday, 21 February 2019, 9:14 AM
P147 Systematic review: diverting loop ileostomy as treatment option in severe inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. STEENHUIS, K. van Son

Created: Thursday, 30 January 2020, 10:12 AM
P147: Do IBD Patient Treatment Outcomes Expectations Differ by Ethnicity and Gender?
Year: 2022
Source: ECCO'22
Authors: Broide, E.(1);Richter, V.(2);Mari, A.(3);Khoury, T.(3);Shirin, H.(2);Naftali, T.(4);
Created: Friday, 11 February 2022, 3:52 PM
P147: Metabolomics discriminate children with Crohn's disease from ulcerative colitis and from healthy controls – preliminary study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Daniluk U.1, Ciborowski M.2, Daniluk J.*3, Pietrowska K.2, Kretowski A.2, Lebensztejn D.1

Created: Wednesday, 20 February 2019, 10:36 AM
P147: Presence of granulomas in tissue samples from Crohn’s disease patients correlates with specific disease characteristics
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Koureta1*, S. Siakavellas1, I. Delladetsima2, M. Perdiki2, G. Papatheodoridis1, G. Bamias3

Created: Thursday, 21 February 2019, 9:14 AM
P147: Progression to biologic treatment in very early onset inflammatory bowel disease patients- a long term follow up retrospective study
Year: 2021
Source: ECCO'21 Virtual
Authors: Eindor, A.(1);Meleady, L.(1);Jacobson, K.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P147: The valuation of the Short Inflammatory Bowel Disease Questionnaire for use in economic evaluations
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Petryszyn*1, P. Piotrowski2, P. Ekk-Cierniakowski3, A. Staniak1, M. Well4

Created: Friday, 22 February 2019, 9:49 AM
P147: Thromboembolic complications in patients with Inflammatory bowel disease predict poor prognosis: a large North Indian cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Yadukrishna*1, V. Teja1, S. Kedia1, S. Jain1, P. Sahu1, S. Kumar1, G. Makharia1, V. Ahuja1

Created: Friday, 22 February 2019, 9:41 AM
P147: Trends in choice of first line biologic therapy for patients with Inflammatory Bowel Disease. An observational cohort study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fernando, S.(1)*;Abu-Rgeef, R.(1);Menon, S.(1);So, K.(1);Venugopal, K.(1);Picardo, S.(1);
Created: Friday, 14 July 2023, 10:48 AM
P148 has been withdrawn.:
Year: 2018
Source: ECCO '18 Vienna
Authors:

Created: Thursday, 21 February 2019, 9:14 AM
P148 Reproducibility of PICaSSO score by using narrow banding images (NBI) to assess mucosal and histological healing in ulcerative colitis (UC) patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Cannatelli1,2, O. Nardone1, U. Shivaji1,3, S.C.L. Smith1,3, A. Bazarova4, D. Zardo5, S. Ghosh1,3,6, M. Iacucci1,3,6

Created: Thursday, 30 January 2020, 10:12 AM
P148: ANA and Anti-dsDNA antibody enabling the prediction of inflammatory arthritis in inflammatory bowel disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: de Sousa Magalhães, R.(1,2,3);Lima Capela, T.(1,2,3);Rosa, B.(1,2,3);Moreira, M.J.(1,2,3);Cotter, J.(1,2,3);
Created: Wednesday, 2 June 2021, 4:12 PM
P148: Fecal calprotectin as a noninvasive indicator for ulcerative colitis disease activity in the Korean cohort
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lee S.-H.*1, Seo H.1, Chang K.1, Song E.M.1, Kim G.-U.1, Seo M.1, Kwon E.J.1,2, Hwang S.W.1,2, Park S.H.1,2, Yang D.-H.1, Kim K.-J.1, Byeon J.-S.1, Myung S.-J.1, Yang S.-K.1,2, Ye B.D.1,2

Created: Wednesday, 20 February 2019, 10:36 AM